Table I.
Results of the counselling conducted by the Apulian working group in patients affected by head and neck cancer.
| Number of patients (%) |
Severity of symptoms (± SD) * |
|
|---|---|---|
| Family history of COVID-19 (RT-PCR confirmed cases) |
1 (0.4%) | N/A |
| Body temperature (≥ 38°) | 5 (2.0%) | N/A |
| Cough | 154 (60%) | 1.5 (± 1.4) |
| Dyspnoea | 66 (25.7%) | 0.4 (± 0.7) |
| Fatigue | 56 (21.8%) | 0.3 (± 0.7) |
| Myalgia | 54 (21.0%) | 0.3 (± 0.7) |
| Cephalalgia | 39 (15.2%) | 0.2 (± 0.6) |
| Smell/taste impairment (worsening) | 101 (39.3%) | 0.7 (± 1.2) |
* Patients were invited to rate their symptoms by using a 0-5 scale, where 0 indicated ‘no problem’ and 5 a ‘very intense problem’. N/A: not applicable; RT-PCR: reverse transcription polymerase chain reaction.